SOURCE: Market Pulse

May 23, 2005 08:30 ET

Market Pulse Breaking News Alert for Monday, May 23, 2005: BIPH - Biophan CEO Michael Weiner to Present at 4th Annual NanoBusiness Conference 2005 in New York City!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- May 23, 2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Biophan Technologies, Inc. (OTC BB: BIPH), Able Laboratories Inc. (NASDAQ: ABRX), Sirius Satellite Radio Inc. (NASDAQ: SIRI), and Intel Corp. (NASDAQ: INTC).

Investors need to be watching Biophan Technologies, Inc. (OTC BB: BIPH) this AM! Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. Biophan's technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. BIPH has had several excellent news announcements lately and one again before today's opening bell regarding their CEO Michael Weiner presenting at the fourth annual NanoBusiness Conference 2005 in New York City! This could be great news for investors!

Biophan Technologies, Inc. (OTC BB: BIPH), a developer of next-generation medical technology, will present an overview of its innovative nanotechnologies for the biomedical sector, and its high-growth business strategy to ensure growth through aggressive protection and enforcement of patents. Biophan CEO Michael Weiner will describe the Company's nanotechnology solutions for multi-billion-dollar healthcare markets as a featured company at the 4th Annual NanoBusiness Conference 2005, to be held May 22 - 25, at the New York Marriott Financial Center, in New York, NY.

The four-day event will bring together leading nanotechnology companies and a range of guest speakers with a mix of scientific, investment, and industry experience. Delivering the keynote addresses are New York Senator Charles E. Schumer and Senator Ron Wyden.

Mr. Weiner will discuss the Biophan patent portfolio and its proprietary technologies in a half-hour presentation on May 25th, starting at 1:30 p.m. in the Grand ballroom.

"Biophan's successful research and development program has already yielded a uniquely broad patent thicket in a number of advanced nanotechnology solutions in next-generation medical device and healthcare markets," said Mr. Weiner. "The business we're in requires a strategy of both aggressive research and development, as well as protection of our proprietary biomedical and pharmaceutical industry solutions. Biophan has an unusually large intellectual property portfolio of more than 114 patents, applications, or licenses. This is a key component of the Company's high-growth strategy to generate licensing revenues from several multi-billion-dollar areas of the healthcare industry."

For more information about the 4th Annual NanoBusiness Conference 2005, please visit: http://www.nanoevent.com/

About NanoBusiness 2005

NanoBusiness 2005 is nanotechnology's foremost business conference, intended for key stakeholders in the business of small technology, and will again gather hundreds of CEOs, business leaders, investors, scientists and engineers for four intensive days of seminars, presentations, keynotes and networking events. NanoBusiness 2005 provides the information required to profit from the transformation of nanotechnology into nanobusiness.

About Biophan Technologies

Biophan develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with the magnetic resonance imaging (MRI) environment. The Company develops enabling technologies for implanted medical systems such as pacemakers and interventional surgical devices such as catheters, guidewires, stents, and other implants to allow them to be safely and effectively imaged under MRI. The technology is also being used to create MRI contrast agents, and has expanded to include other applications, such as drug delivery and power systems derived from body heat. Four Biophan technologies include advances in nanotechnology and thin film coatings. Committed to growth through innovation and developmental leadership, Biophan and its licensors now hold a total of 114 U.S. patents, licenses, or applications. This total includes 36 issued U.S. patents, 6 recently-allowed applications that will issue as patents in the near future, and 72 pending applications at various stages of examination at the U.S. Patent and Trademark Office, plus international applications. The patents cover areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, thermoelectric materials for batteries generating power from body heat, and photonics. Biophan has joint development arrangements with Boston Scientific and NASA's Ames Center for Nanotechnology. Biophan's goal is to make all biomedical devices capable of safely and successfully working with MRI, and delivering other technologies which will improve quality of life. For more information, please visit www.biophan.com.

Stocks acting well as of late include: Able Laboratories Inc. (NASDAQ: ABRX), Sirius Satellite Radio Inc. (NASDAQ: SIRI), and Intel Corp. (NASDAQ: INTC).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated one hundred fifty thousand dollars from Biophan Technologies, Inc. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.

Contact Information